ROYCE & ASSOCIATES LP

Holdings History for OptimizeRx Corp - Common Stock, par value $0.001 (OPRX)

Symbol: OPRX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.001
Latest Disclosed Ownership: 1.07M shares
Security Ownership: 5.81%

Shares, Excluding Options vs Price

Value, Excluding Options

ROYCE & ASSOCIATES LP ownership in OptimizeRx Corp Common Stock, par value $0.001 (OPRX)

2025-01-28 - ROYCE & ASSOCIATES LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.07M shares of OptimizeRx Corp Common Stock, par value $0.001 (OPRX). This represents 5.81% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
ROYCE & ASSOCIATES LP	5.81%		$9.26M	1.07M			$8.66	13G	12/31/2024	28 Jan 2025 12:58:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.05%	+0.05%	$5.2M	1.07M	+1,069,560	NEW	$4.86	Q4 2024
9/30/2022		-0.01%	$0	0	-44,000	-100%		Q3 2022
6/30/2022	0.01%		$1.21M	44K			$27.39	Q2 2022
3/31/2022	0.01%	+0.01%	$1.66M	44K	+44,000	NEW	$37.70	Q1 2022
12/31/2021		-0.01%	$0	0	-11,450	-100%		Q4 2021
9/30/2021	0.01%	-0.01%	$980K	11.5K	-13,750	-54.6%	$85.59	Q3 2021
6/30/2021	0.01%	+0%	$1.56M	25.2K	+800	+3.28%	$61.90	Q2 2021
3/31/2021	0.01%	+0%	$1.19M	24.4K	+1,500	+6.55%	$48.77	Q1 2021
12/31/2020	0.01%	+0%	$714K	22.9K	+2,900	+14.5%	$31.18	Q4 2020
9/30/2020	0%	+0%	$417K	20K	+5,100	+34.2%	$20.85	Q3 2020
6/30/2020	0%	+0%	$194K	14.9K	+14,900	NEW	$13.02	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.